Member Info for smkr

Hey Alloa. Hope you’re well. Tnt certainly isn’t a scam. They’ve electronic money license(s), partnerships with Temenos among others, patents in, high level board members who mix in Government circles. As you know I changed my personal view on it only because of the way the funding was delivered after being promised a different way, but other than that- which the trolls seem to have had a field day with- everything is still moving forwards it seems. Hope all the old guys are doing well, I might venture back in here again eventually. When I feel time is right for me.

Looking promising so far. If this comes in then it will be first of many. Interesting times, fingers crossed.

Damn right it will hurt. Was 860m m/c .. I’d be surprised if some of his other holdings don’t sell down too.

RG held over 5% of Wandisco that’s gone to the dogs .. somebody mentioned to me done leveraged position too. That will be the reason. Once he’s gone (and it’s probably nearly there) load up the f*cking boat.

And for clarity on how significant this deal is..

The $17.5m is over double the amount raised by the company via placings and loan notes over the last 3 years- which advanced the Lithium to this stage.

I think a lot of people are forgetting the gold. $100m is allocated to Lithium by Fosun International.
But we have some excellent Gold assets..

From RNS..

“The US$17.75 million raised from the Subscription will be used to advance the Company's portfolio of gold exploration assets in Mali and Cote d'Ivoire”

This new test won’t be the last either, I think the wider market doesn’t realise the power on OBDs Episwitch platform. They have huge data sets and are looking to use that to bring many tests to market .. hence this new prostate screening. This data platform alone is so valuable

https://www.oxfordbiodynamics.com/episwitch-platform

Hey Goodgreef, we already have a test that is accurate at telling you whether a patient will respond to immunotherapy treatment for cancer, typically only around 30% of cancer patients respond to the treatment and for some that have it they also have bad reactions.

The reimbursement code was granted before new year which means it can now be reclaimed on usa health insurance. Hopefully sales push on from here in 2023.

https://www.mycirt.com/

https://www.businesswire.com/news/home/20230206005369/en/Oxford-BioDynamics%E2%80%99-Prostate-Screening-EpiSwitch%C2%AE-Blood-Test-Significantly-Enhances-Overall-Detection-Accuracy-For-At-Risk-Men

I don’t think I’ll ever figure out what people want from a trading update lol :-) it’s a hold.

nice update.,

As stated at the time of the Group's IPO, Sondrel expects typical production volumes for each contract to deliver revenue of GBP10m to GBP100m per annum and the contract with the Tier 1 Automotive customer could deliver production revenue at the upper end of this range.

Couple of big delay buys there at high price of day. Someone took a decent position

https://www.standard.co.uk/news/health/imperial-college-oxford-biodynamics-nhs-prostate-cancer-b1058671.html

NHS might be forced to look into this with accuracy and national coverage imo

ITV too

https://www.itv.com/news/2023-02-07/new-blood-test-for-prostate-cancer-is-94-accurate-researchers-say

https://www.dailymail.co.uk/health/article-11724915/New-blood-test-92-accurate-spotting-signs-prostate-cancer-study-says.html

https://www.telegraph.co.uk/business/2023/01/25/britain-challenge-china-1bn-subsidies-computer-chip-makers/

Yes looks like you are right. No way that price was a sell over last couple days if it was worked through

Whopper of a sell cleared just there

New website design. Very nice has to be said

https://www.oxfordbiodynamics.com/